| Year |
Citation |
Score |
| 2012 |
Kong Q, Carothers S, Chang Y, Glenn Lin CL. The importance of preclinical trial timing - a potential reason for the disconnect between mouse studies and human clinical trials in ALS. Cns Neuroscience & Therapeutics. 18: 791-3. PMID 22712693 DOI: 10.1111/J.1755-5949.2012.00358.X |
0.319 |
|
| 2008 |
Kong Q, Stockinger MP, Chang Y, Tashiro H, Lin CL. The presence of rRNA sequences in polyadenylated RNA and its potential functions. Biotechnology Journal. 3: 1041-6. PMID 18683164 DOI: 10.1002/Biot.200800122 |
0.38 |
|
| 2008 |
Chang Y, Kong Q, Shan X, Tian G, Ilieva H, Cleveland DW, Rothstein JD, Borchelt DR, Wong PC, Lin CL. Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. Plos One. 3: e2849. PMID 18682740 DOI: 10.1371/Journal.Pone.0002849 |
0.586 |
|
| 2008 |
Kong Q, Shan X, Chang Y, Tashiro H, Lin CL. RNA oxidation: a contributing factor or an epiphenomenon in the process of neurodegeneration. Free Radical Research. 42: 773-7. PMID 18661427 DOI: 10.1080/10715760802311187 |
0.577 |
|
| 2008 |
Chang Y, Stockinger MP, Tashiro H, Lin CL. A novel noncoding RNA rescues mutant SOD1-mediated cell death. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 691-702. PMID 17957031 DOI: 10.1096/Fj.07-9532Com |
0.456 |
|
| 2007 |
Shan X, Chang Y, Lin CL. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 2753-64. PMID 17496160 DOI: 10.1096/Fj.07-8200Com |
0.59 |
|
| 2007 |
Tian G, Lai L, Guo H, Lin Y, Butchbach ME, Chang Y, Lin CL. Translational control of glial glutamate transporter EAAT2 expression. The Journal of Biological Chemistry. 282: 1727-37. PMID 17138558 DOI: 10.1074/Jbc.M609822200 |
0.52 |
|
| Show low-probability matches. |